{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:24:22Z","timestamp":1794558262767,"version":"4.9.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation of China","doi-asserted-by":"crossref","award":["2023JJ50060"],"award-info":[{"award-number":["2023JJ50060"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-88478-3","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T22:36:52Z","timestamp":1740695812000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Association between TyG-related parameters and NAFLD risk in Japanese non-obese population"],"prefix":"10.1038","volume":"15","author":[{"given":"Xiuli","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanxiong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"key":"88478_CR1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12916-014-0137-y","volume":"12","author":"R Jim\u00e9nez-Ag\u00fcero","year":"2014","unstructured":"Jim\u00e9nez-Ag\u00fcero, R. et al. Novel equation to determine the hepatic triglyceride concentration in humans by Mri: Diagnosis and monitoring of Nafld in obese patients before and after bariatric surgery. BMC Med. 12, 137 (2014).","journal-title":"BMC Med."},{"key":"88478_CR2","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/hep.31031","volume":"72","author":"S Hwang","year":"2020","unstructured":"Hwang, S. et al. Interleukin-22 ameliorates neutrophil-driven nonalcoholic steatohepatitis through multiple targets. Hepatology 72, 412\u2013429 (2020).","journal-title":"Hepatology"},{"key":"88478_CR3","first-page":"E613","volume":"315","author":"L Meoli","year":"2018","unstructured":"Meoli, L. et al. Nonalcoholic fatty liver disease and gastric bypass surgery regulate serum and hepatic levels of pyruvate kinase isoenzyme M2. Am. J. Physiol-endoc M. 315, E613\u2013E621 (2018).","journal-title":"Am. J. Physiol-endoc M"},{"key":"88478_CR4","doi-asserted-by":"crossref","unstructured":"Tan, Y. et al. Perilipin 5 protects against Cellular oxidative stress by enhancing mitochondrial function in Hepg2 cells. Cells-basel 8, (2019).","DOI":"10.3390\/cells8101241"},{"key":"88478_CR5","first-page":"3","volume":"9","author":"S Liu","year":"2021","unstructured":"Liu, S. et al. Systematic review and Meta-analysis of circulating Fetuin-a levels in nonalcoholic fatty liver disease. J. Clin. Transl Hepato. 9, 3\u201314 (2021).","journal-title":"J. Clin. Transl Hepato"},{"key":"88478_CR6","doi-asserted-by":"publisher","first-page":"752999","DOI":"10.3389\/fmed.2021.752999","volume":"8","author":"Y Xia","year":"2021","unstructured":"Xia, Y. et al. Longitudinal associations between Hand grip Strength and non-alcoholic fatty liver disease in adults: A prospective cohort study. FRONT. MED-LAUSANNE. 8, 752999 (2021).","journal-title":"FRONT. MED-LAUSANNE"},{"key":"88478_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/CM9.0000000000001263","volume":"134","author":"YX Xian","year":"2020","unstructured":"Xian, Y. X., Weng, J. P. & Xu, F. Mafld Vs. Nafld: Shared features and potential changes in epidemiology, pathophysiology, diagnosis, and Pharmacotherapy. Chin. MED. J-PEKING. 134, 8\u201319 (2020).","journal-title":"Chin. MED. J-PEKING"},{"key":"88478_CR8","doi-asserted-by":"crossref","unstructured":"Nagatomo, A. et al. A Gedunin-Type Limonoid, 7-Deacetoxy-7-Oxogedunin, from Andiroba (Carapa Guianensis Aublet) reduced intracellular triglyceride content and enhanced autophagy in Hepg2 cells. Int. J. Mol. Sci. 23, (2022).","DOI":"10.3390\/ijms232113141"},{"key":"88478_CR9","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1021\/acs.jproteome.6b00601","volume":"15","author":"L Li","year":"2016","unstructured":"Li, L. et al. Proteome Dynamics reveals pro-inflammatory remodeling of plasma proteome in a mouse model of Nafld. J. Proteome Res. 15, 3388\u20133404 (2016).","journal-title":"J. Proteome Res."},{"key":"88478_CR10","doi-asserted-by":"crossref","unstructured":"Seo, D. H. & Kim, S. H. Advanced Liver Fibrosis is Associated with Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (Diabetes Metab J ;46:630-9). DIabetes Metab J. 46, 956\u2013957 (2022). (2022).","DOI":"10.4093\/dmj.2022.0381"},{"key":"88478_CR11","first-page":"1027","volume":"10","author":"D Song","year":"2022","unstructured":"Song, D. et al. Development and validation of a Nomogram for Prediction of the risk of Mafld in an overweight and obese Population. J. Clin. Transl Hepato. 10, 1027\u20131033 (2022).","journal-title":"J. Clin. Transl Hepato"},{"key":"88478_CR12","doi-asserted-by":"crossref","unstructured":"Pittala, S. et al. The Vdac1-Based R-Tf-D-Lp4 Peptide as a Potential Treatment for Diabetes Mellitus. Cells-basel. 9, (2020).","DOI":"10.3390\/cells9020481"},{"key":"88478_CR13","doi-asserted-by":"publisher","first-page":"8364","DOI":"10.3748\/wjg.v20.i26.8364","volume":"20","author":"O Kucera","year":"2014","unstructured":"Kucera, O. & Cervinkova, Z. Experimental models of non-alcoholic fatty liver disease in rats. World J. Gastroentero. 20, 8364\u20138376 (2014).","journal-title":"World J. Gastroentero"},{"key":"88478_CR14","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1186\/s12967-020-02637-w","volume":"18","author":"X Yuan","year":"2020","unstructured":"Yuan, X. et al. Circular rna expression profiles and features in Nafld mice: A study using rna-Seq Data. J. Transl Med. 18, 476 (2020).","journal-title":"J. Transl Med."},{"key":"88478_CR15","doi-asserted-by":"publisher","first-page":"774937","DOI":"10.3389\/fonc.2021.774937","volume":"11","author":"L Wang","year":"2021","unstructured":"Wang, L. et al. Triglyceride-glucose index is not Associated with Lung Cancer risk: A prospective cohort study in the Uk Biobank. Front. Oncol. 11, 774937 (2021).","journal-title":"Front. Oncol."},{"key":"88478_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12944-017-0409-6","volume":"16","author":"S Zhang","year":"2017","unstructured":"Zhang, S. et al. The triglyceride and glucose index (tyg) is an effective biomarker to identify nonalcoholic fatty liver disease. Lipids Health Dis. 16, 15 (2017).","journal-title":"Lipids Health Dis."},{"key":"88478_CR17","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.2147\/DMSO.S383907","volume":"15","author":"R Zhang","year":"2022","unstructured":"Zhang, R. et al. Association between triglyceride-glucose Index and Risk of Metabolic Dysfunction-Associated fatty liver disease: A Cohort Study. Diabet. Metab. Synd OB. 15, 3167\u20133179 (2022).","journal-title":"Diabet. Metab. Synd OB"},{"key":"88478_CR18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12944-021-01506-9","volume":"20","author":"R Wang","year":"2021","unstructured":"Wang, R., Dai, L., Zhong, Y. & Xie, G. Usefulness of the triglyceride glucose-body Mass Index in evaluating nonalcoholic fatty liver disease: Insights from a General Population. Lipids Health Dis. 20, 77 (2021).","journal-title":"Lipids Health Dis."},{"key":"88478_CR19","doi-asserted-by":"publisher","first-page":"949831","DOI":"10.3389\/fendo.2022.949831","volume":"13","author":"W Xuan","year":"2022","unstructured":"Xuan, W., Liu, D., Zhong, J., Luo, H. & Zhang, X. Impacts of triglyceride glucose-Waist to height ratio on diabetes incidence: A secondary analysis of a Population-based Longitudinal Data. FRONT. ENDOCRINOL. 13, 949831 (2022).","journal-title":"FRONT. ENDOCRINOL."},{"key":"88478_CR20","doi-asserted-by":"publisher","first-page":"888","DOI":"10.3389\/fphar.2018.00888","volume":"9","author":"X Chen","year":"2018","unstructured":"Chen, X. et al. LncRNA-AK012226 is involved in fat accumulation in db\/db mice fatty liver and non-alcoholic fatty liver disease cell model. Front. Pharmacol. 9, 888 (2018).","journal-title":"Front. Pharmacol."},{"key":"88478_CR21","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/ijo.2015.226","volume":"40","author":"P Mulder","year":"2016","unstructured":"Mulder, P. et al. Surgical removal of inflamed epididymal white adipose tissue attenuates the development of non-alcoholic steatohepatitis in obesity. Int. J. Obes. 40, 675\u2013684 (2016).","journal-title":"Int. J. Obes."},{"key":"88478_CR22","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.cgh.2016.08.028","volume":"15","author":"D Kim","year":"2017","unstructured":"Kim, D. & Kim, W. R. Nonobese fatty liver disease. Clin. Gastroenterol. Hepatol. 15, 474\u2013485 (2017).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"88478_CR23","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.3748\/wjg.v26.i15.1792","volume":"26","author":"J Zeng","year":"2020","unstructured":"Zeng, J. et al. Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease. World J. Gastroenterol. 26, 1792\u20131804 (2020).","journal-title":"World J. Gastroenterol."},{"key":"88478_CR24","doi-asserted-by":"publisher","first-page":"e6712","DOI":"10.1097\/MD.0000000000006712","volume":"96","author":"H Yoshitaka","year":"2017","unstructured":"Yoshitaka, H. et al. Nonoverweight nonalcoholic fatty liver disease and incident cardiovascular disease: A post hoc analysis of a cohort study. Med. (Baltimore). 96, e6712 (2017).","journal-title":"Med. (Baltimore)"},{"key":"88478_CR25","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12944-020-01409-1","volume":"19","author":"Y Li","year":"2020","unstructured":"Li, Y. et al. Association between triglyceride glucose-body mass index and non-alcoholic fatty liver disease in the non-obese Chinese population with normal blood lipid levels: A secondary analysis based on a prospective cohort study. Lipids Health Dis. 19, 229 (2020).","journal-title":"Lipids Health Dis."},{"key":"88478_CR26","doi-asserted-by":"publisher","first-page":"1429413","DOI":"10.3389\/fmed.2024.1429413","volume":"11","author":"Q Ning","year":"2024","unstructured":"Ning, Q., Zheng, K., Yan, J. & Zhu, C. Triglyceride glucose index as a predictor for non-alcoholic fatty liver disease: insights from a longitudinal analysis in non-obese individuals. Front. Med. (Lausanne). 11, 1429413 (2024).","journal-title":"Front. Med. (Lausanne)"},{"key":"88478_CR27","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41366-018-0076-3","volume":"43","author":"T Okamura","year":"2019","unstructured":"Okamura, T. et al. Ectopic Fat obesity presents the Greatest Risk for Incident Type 2 diabetes: A Population-based longitudinal study. INT. J. Obes. 43, 139\u2013148 (2019).","journal-title":"INT. J. Obes."},{"key":"88478_CR28","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12933-021-01391-7","volume":"20","author":"YW Lu","year":"2021","unstructured":"Lu, Y. W. et al. Gender difference in the Association between Tyg Index and subclinical atherosclerosis: results from the I-Lan Longitudinal Aging Study. CARDIOVASC. DIABETOL. 20, 206 (2021).","journal-title":"Cardiovasc. Diabetol."},{"key":"88478_CR29","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13098-022-00855-4","volume":"14","author":"X Zhang","year":"2022","unstructured":"Zhang, X. et al. Association of metabolic syndrome with Tyg Index and Tyg-related parameters in an Urban Chinese Population: A 15-Year prospective study. Diabetol. Metab. Syndr. 14, 84 (2022).","journal-title":"Diabetol. Metab. Syndr."},{"key":"88478_CR30","doi-asserted-by":"publisher","first-page":"d3897","DOI":"10.1136\/bmj.d3897","volume":"343","author":"QM Anstee","year":"2011","unstructured":"Anstee, Q. M., McPherson, S. & Day, C. P. How big a problem is non-alcoholic fatty liver disease? BMJ-Brit Med. J. 343, d3897 (2011).","journal-title":"BMJ-Brit Med. J."},{"key":"88478_CR31","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam, M. et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J. Hepatol. 73, 202\u2013209 (2020).","journal-title":"J. Hepatol."},{"key":"88478_CR32","doi-asserted-by":"publisher","first-page":"664","DOI":"10.3390\/metabo12070664","volume":"12","author":"AL Han","year":"2022","unstructured":"Han, A. L. & Lee, H. K. Comparison of the diagnostic performance of steatosis indices for discrimination of CT-diagnosed metabolic dysfunction-associated fatty liver disease. Metabolites 12, 664 (2022).","journal-title":"Metabolites"},{"key":"88478_CR33","doi-asserted-by":"publisher","first-page":"5186","DOI":"10.3390\/cancers13205186","volume":"13","author":"E Pawluczuk","year":"2021","unstructured":"Pawluczuk, E., \u0141ukaszewicz-Zaj\u0105c, M., Gryko, M., Kulczy\u0144ska-Przybik, A. & Mroczko, B. Serum CXCL8 and its specific receptor (CXCR2) in gastric Cancer. Cancers (Basel). 13, 5186 (2021).","journal-title":"Cancers (Basel)"},{"key":"88478_CR34","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.3390\/ijms23031917","volume":"23","author":"H van der Staaij","year":"2022","unstructured":"van der Staaij, H. et al. Transferrin Saturation\/Hepcidin ratio discriminates TMPRSS6-Related Iron Refractory Iron Deficiency Anemia from patients with Multi-causal Iron Deficiency Anemia. Int. J. Mol. Sci. 23, 1917 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"88478_CR35","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1210\/jc.2010-0288","volume":"95","author":"F Guerrero-Romero","year":"2010","unstructured":"Guerrero-Romero, F. et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the Euglycemic-Hyperinsulinemic Clamp. J. Clin. Endocr. Metab. 95, 3347\u20133351 (2010).","journal-title":"J. Clin. Endocr. Metab."},{"key":"88478_CR36","doi-asserted-by":"publisher","first-page":"843072","DOI":"10.3389\/fendo.2022.843072","volume":"13","author":"Q Guo","year":"2022","unstructured":"Guo, Q. et al. Influence of the triglyceride-glucose index on adverse Cardiovascular and cerebrovascular events in prediabetic patients with Acute Coronary Syndrome. Front. Endocrinol. 13, 843072 (2022).","journal-title":"Front. Endocrinol."},{"key":"88478_CR37","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s12967-016-1020-8","volume":"14","author":"S Zheng","year":"2016","unstructured":"Zheng, S. et al. Triglyceride glucose-Waist circumference, a Novel and effective predictor of diabetes in First-Degree relatives of type 2 diabetes Patients: cross-sectional and prospective cohort study. J. Transl Med. 14, 260 (2016).","journal-title":"J. Transl Med."},{"key":"88478_CR38","doi-asserted-by":"publisher","first-page":"907973","DOI":"10.3389\/fendo.2022.907973","volume":"13","author":"B Song","year":"2022","unstructured":"Song, B. et al. Triglyceride glucose-body Mass Index and Risk of Incident Type 2 diabetes Mellitus in Japanese people with normal glycemic level: A Population-based longitudinal cohort study. Front. Endocrinol. 13, 907973 (2022).","journal-title":"Front. Endocrinol."},{"key":"88478_CR39","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1089\/met.2020.0109","volume":"19","author":"ME Khamseh","year":"2021","unstructured":"Khamseh, M. E. et al. Triglyceride glucose index and related parameters (triglyceride glucose-body Mass Index and triglyceride glucose-Waist circumference) identify nonalcoholic fatty liver and liver fibrosis in individuals with Overweight\/Obesity. Metab. Syndr. Relat. D. 19, 167\u2013173 (2021).","journal-title":"Metab. Syndr. Relat. D"},{"key":"88478_CR40","doi-asserted-by":"crossref","unstructured":"Kim, H. S. et al. Triglyceride glucose-Waist circumference is Superior to the Homeostasis Model Assessment of Insulin Resistance in identifying nonalcoholic fatty liver disease in healthy subjects. J. Clin. Med. 11, (2021).","DOI":"10.3390\/jcm11010041"},{"key":"88478_CR41","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3350\/cmh.2013.19.2.140","volume":"19","author":"DY Ju","year":"2013","unstructured":"Ju, D. Y. et al. The influence of Waist circumference on insulin resistance and nonalcoholic fatty liver disease in apparently healthy Korean adults. CLIN. MOL. HEPATOL. 19, 140\u2013147 (2013).","journal-title":"CLIN. MOL. HEPATOL."},{"key":"88478_CR42","doi-asserted-by":"publisher","first-page":"1308265","DOI":"10.3389\/fendo.2023.1308265","volume":"14","author":"AH Kim","year":"2023","unstructured":"Kim, A. H., Son, D. H. & Lee, Y. J. Modified triglyceride-glucose index indices are Reliable markers for Predicting Risk of Metabolic Dysfunction-Associated fatty liver disease: A cross-sectional study. Front. Endocrinol. 14, 1308265 (2023).","journal-title":"Front. Endocrinol."},{"key":"88478_CR43","doi-asserted-by":"crossref","unstructured":"Song, K. et al. Comparison of the Modified Tyg Indices and Other Parameters to Predict Non-Alcoholic Fatty Liver Disease in Youth. Biology-Basel. 11, (2022).","DOI":"10.3390\/biology11050685"},{"key":"88478_CR44","doi-asserted-by":"publisher","first-page":"e7041","DOI":"10.1097\/MD.0000000000007041","volume":"96","author":"S Zhang","year":"2017","unstructured":"Zhang, S. et al. Triglyceride glucose-body Mass Index is effective in identifying nonalcoholic fatty liver disease in nonobese subjects. MEDICINE 96, e7041 (2017).","journal-title":"MEDICINE"},{"key":"88478_CR45","doi-asserted-by":"publisher","first-page":"20470","DOI":"10.1038\/s41598-023-47269-4","volume":"13","author":"P Zeng","year":"2023","unstructured":"Zeng, P., Cai, X., Yu, X. & Gong, L. Markers of insulin resistance associated with non-alcoholic fatty liver disease in non-diabetic population. Sci. Rep. 13, 20470 (2023).","journal-title":"Sci. Rep."},{"key":"88478_CR46","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1186\/s12876-023-03007-8","volume":"23","author":"S Li","year":"2023","unstructured":"Li, S. et al. Triglyceride glucose-waist circumference: the optimum index to screen nonalcoholic fatty liver disease in non-obese adults. BMC Gastroenterol. 23, 376 (2023).","journal-title":"BMC Gastroenterol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88478-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88478-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88478-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T22:36:59Z","timestamp":1740695819000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88478-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["88478"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-88478-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4291578\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"assertion":[{"value":"19 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7119"}}